Patent · US Active

Assay for drug discovery based on in vitro differentiated cells

US9726662B2 · kind B2 · utility

0Cited by

23References

22Claims

0Family size

Assignee

AXIOGENESIS AG · DE

Inventors

Heribert Bohlen · Cologne, DE
Kristina Jönsson
Andreas Ehlich · Mechernich, DE
Silke Schwengberg · St. Blasien, DE

Key dates

Filing date	Jan 15, 2016
Grant date	Aug 8, 2017
Priority date	—
Expiry date	Jan 15, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Provided are assay systems for determining the therapeutic or toxic effect of a putative drug based on assaying its activity in cells which have been differentiated in vitro from stem cells, and induced to display a phenotype that resembles a disease to be treated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.